Leverkusen, Germany – Olivier Brandicourt has been appointed chairman of the board of management of Bayer HealthCare and member of the Bayer AG executive council, effective November 1, 2013.[break]
Mr. Brandicourt has 25 years of international experience in the pharmaceutical industry, including executive responsibilities in France, the United States, Canada and the United Kingdom. He has been a member of the Executive Leadership Team of Pfizer Inc., New York, USA, for the last three years.
Until recently he was President and General Manager of the Emerging Markets and Established Products Business Units. Before that he held senior operational positions as President of the Global Specialty Business Unit, and until 2012 he was head of the Global Primary Care Business Unit.
Furthermore, he previously held senior regional and country management positions at Pfizer and positions across a range of disciplines including medical and marketing at Warner - September 30, 2013, Leverkusen, Germany – Olivier Brandicourt has been appointed chairman of the board of management of Bayer HealthCare and member of the Bayer AG executive council, effective November 1, 2013.
Article continues below
]
Mr. Brandicourt has 25 years of international experience in the pharmaceutical industry, including executive responsibilities in France, the United States, Canada and the United Kingdom. He has been a member of the Executive Leadership Team of Pfizer Inc., New York, USA, for the last three years.
Until recently he was President and General Manager of the Emerging Markets and Established Products Business Units. Before that he held senior operational positions as President of the Global Specialty Business Unit, and until 2012 he was head of the Global Primary Care Business Unit.
Furthermore, he previously held senior regional and country management positions at Pfizer and positions across a range of disciplines including medical and marketing at Warner-Lambert/Parke-Davis.
Mr. Brandicourt holds a medical degree with a subspecialty in infectious diseases and tropical medicine, as well as a master’s degree in biology from Paris 12 University, France. ■
LATEST MOVES FROM Leverkusen, Germany – Olivier Brandicourt has been appointed chairman of the board of management of Bayer HealthCare and member of the Bayer AG executive council, effective November 1, 2013.[break]
Mr. Brandicourt has 25 years of international experience in the pharmac